2014
DOI: 10.1016/j.vaccine.2013.11.078
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of recombinant fusion protein comprising dog zona pellucida glycoprotein-3 and Izumo and individual fragments as immunogens for contraception

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 33 publications
2
14
0
Order By: Relevance
“…Subsequently, four studies have been published exploring Izumo1 as a contraceptive immunogen. Three of these studies confirmed our findings and reported a significant reduction in fertility of female mice after immunization with Izumo1 protein or cDNA . The fourth article concluded that immunization with Izumo1 does not cause a contraceptive effect in male and female mice.…”
Section: Izumo Proteinsupporting
confidence: 84%
See 3 more Smart Citations
“…Subsequently, four studies have been published exploring Izumo1 as a contraceptive immunogen. Three of these studies confirmed our findings and reported a significant reduction in fertility of female mice after immunization with Izumo1 protein or cDNA . The fourth article concluded that immunization with Izumo1 does not cause a contraceptive effect in male and female mice.…”
Section: Izumo Proteinsupporting
confidence: 84%
“…(2) The authors used His 6 ‐tag recombinant Izumo1 protein for immunization. Recent studies have shown that the His 6 ‐tag can affect the efficacy of a vaccine . Antibodies against His 6 ‐tag recombinant Plasmodium falciparum MSP1 have lower percent parasite growth inhibition as compared with antibodies against tag‐free recombinant protein.…”
Section: Izumo Proteinmentioning
confidence: 99%
See 2 more Smart Citations
“…Similarly, porcine ZP4 (aa residues 22-462) was expressed in E. coli as a chimeric fusion protein incorporating a promiscuous T-cell epitope of bovine RNase (bRNase; aa residues 94-104; bRNase-KK-ZP4) [15]. Recombinant proteins were purified from inclusion bodies followed by refolding, as described previously [17]. Recombinant TT-KK-ZP3 and bRNase-KK-ZP4 were dialysed separately in 20 mmol/l Tris pH 6.0 and the respective protein concentration estimated using a BCA Protein Estimation Kit c and adjusted to 500 lg/ml.…”
Section: Vaccinesmentioning
confidence: 99%